Back to search

Article

On-target mutations confer resistance to WRN helicase inhibitors in Microsatellite Unstable Cancer Cells

2025-12-27

Abstract excerpt

Werner helicase inhibitors (WRNi) are in clinical development for microsatellite-unstable (MSI) tumors with defective DNA mismatch repair. Here, we investigate how cancer cell evolution shapes response to WRN inhibition and informs potential resistance mechanisms. Genome-wide CRISPR screens combined with WRN knockout did not identify bypass mechanisms, underscoring WRN’s essential, non-redundant function in MSI ce...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fc74df24-25bf-57a6-9d95-2865f45a5757
DOI
10.64898/2025.12.23.695783
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
On-target mutations confer resistance to WRN helicase inhibitors in Microsatellite Unstable Cancer CellsDOI 10.64898/2025.12.23.695783
Select a neighboring publication to make it the new centre.